iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

3/21/25 9:00:00 AM ET

$ACCS

$NXGL

Publishing

Consumer Discretionary

Medical/Dental Instruments

Health Care

Get the next $ACCS alert in real time by email

RALEIGH, NC / ACCESS Newswire / March 21, 2025 / iAccess Alpha's Virtual Best Ideas Spring Investment Conference will take place on March 25-26, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities.

The event begins on Tuesday, March 25, 2025, with a series of live-streamed company presentations, beginning at 9:30 AM ET. The following day, Wednesday, March 26, will be dedicated to 1x1 meetings between presenting companies and investors, starting at 8:00 AM ET.

How to Attend:

Investors and industry professionals can register to watch the presentations and request 1x1 meetings by visiting the official event website: Register Here

Conference Schedule - March 25, 2025 (All Times ET):

Time	Company	Ticker	Webcast Link
9:30am	Nexgel Inc	NASDAQ:NXGL	View Presentation
10:00am	Data Storage Corp	NASDAQ:DTST	View Presentation
10:30am	Callan JMB Inc	NASDAQ:CJMB	View Presentation
11:00am	Intelligent Bio Solutions Inc	NASDAQ:INBS	View Presentation
11:30am	Birchtech Corp	TSX:BCHT, OTCQB:BCHT	View Presentation
12:00pm	Protalix Biotherapeutics Inc	NASDAQ:PLX	View Presentation
12:30pm	Vox Royalty Corp	TSX:VOXR, NASDAQ:VOXR	View Presentation
1:00pm	DoubleDown Interactive	NASDAQ:DDI	View Presentation
1:30pm	Assertio Holdings Inc	NASDAQ:ASRT	View Presentation
2:00pm	Intellicheck Inc	NASDAQ:IDN	View Presentation
2:30pm	ACCESS Newswire Inc	NYSE American:ACCS	View Presentation
3:00pm	Algorhythm Holdings Inc	NASDAQ:RIME	View Presentation

About iAccess Alpha's Virtual Best Ideas Investment Conferences

iAccess Alpha hosts four virtual investment conferences annually (March, June, September, and December), showcasing high-potential small and micro-cap investment opportunities. The conferences feature live company presentations on Day 1, followed by exclusive 1x1 investor meetings on Day 2. Since 2019, iAccess Alpha has co-organized leading microcap-focused events, connecting top-tier investors with high-potential companies.

For more information, contact:
[email protected]
www.iaccessalpha.com

SOURCE: iAccess Alpha

View the original press release on ACCESS Newswire

Get the next $ACCS alert in real time by email

Company

Date

Price Target

Rating

Analyst

NexGel Inc

$NXGL

2/25/2022

$6.00

Buy

Maxim Group

iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

3/21/25 9:00:00 AM ET

$ACCS

$NXGL

Publishing

Consumer Discretionary

Medical/Dental Instruments

Health Care

Get the next $ACCS alert in real time by email

How to Attend:

Investors and industry professionals can register to watch the presentations and request 1x1 meetings by visiting the official event website: Register Here

Conference Schedule - March 25, 2025 (All Times ET):

Time	Company	Ticker	Webcast Link
9:30am	Nexgel Inc	NASDAQ:NXGL	View Presentation
10:00am	Data Storage Corp	NASDAQ:DTST	View Presentation
10:30am	Callan JMB Inc	NASDAQ:CJMB	View Presentation
11:00am	Intelligent Bio Solutions Inc	NASDAQ:INBS	View Presentation
11:30am	Birchtech Corp	TSX:BCHT, OTCQB:BCHT	View Presentation
12:00pm	Protalix Biotherapeutics Inc	NASDAQ:PLX	View Presentation
12:30pm	Vox Royalty Corp	TSX:VOXR, NASDAQ:VOXR	View Presentation
1:00pm	DoubleDown Interactive	NASDAQ:DDI	View Presentation
1:30pm	Assertio Holdings Inc	NASDAQ:ASRT	View Presentation
2:00pm	Intellicheck Inc	NASDAQ:IDN	View Presentation
2:30pm	ACCESS Newswire Inc	NYSE American:ACCS	View Presentation
3:00pm	Algorhythm Holdings Inc	NASDAQ:RIME	View Presentation

About iAccess Alpha's Virtual Best Ideas Investment Conferences

For more information, contact:
[email protected]
www.iaccessalpha.com

SOURCE: iAccess Alpha

View the original press release on ACCESS Newswire

Get the next $ACCS alert in real time by email

Company

Date

Price Target

Rating

Analyst

NexGel Inc

$NXGL

2/25/2022

$6.00

Buy

Maxim Group

iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ACCS
$NXGL

iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ACCS
$NXGL

$ACCS
$NXGL
SEC Filings

NexGel Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

NexGel Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure

SEC Form 424B5 filed by NexGel Inc

$ACCS
$NXGL
Press Releases

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence

NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor

$ACCS
$NXGL
Insider Purchases

Director Pollard Wesley T bought $18,420 worth of shares (2,000 units at $9.21) (SEC Form 4)

Chief Executive Officer Levy Adam R. bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 1% to 333,196 units (SEC Form 4)

Director Zeldis Jerome B bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 4% to 106,664 units (SEC Form 4)

$ACCS
$NXGL
Analyst Ratings

Maxim Group initiated coverage on NexGel with a new price target

$ACCS
$NXGL
Insider Trading

Chief Executive Officer Levy Adam R. sold $15,947 worth of shares (10,000 units at $1.59), decreasing direct ownership by 3% to 357,692 units (SEC Form 4)

Chief Executive Officer Levy Adam R. sold $10,084 worth of shares (4,000 units at $2.52), decreasing direct ownership by 1% to 367,692 units (SEC Form 4)

Director Henry Scott Robert sold $20,360 worth of shares (8,000 units at $2.55), decreasing direct ownership by 7% to 113,356 units (SEC Form 4)

$ACCS
$NXGL
Leadership Updates

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor

NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardiello, CPA, to its Board of Directors

$ACCS
$NXGL
Financials

NEXGEL Reports Third Quarter 2025 Financial Results

NEXGEL to Report Third Quarter 2025 Financial Results on November 11th

NEXGEL Reports Second Quarter 2025 Financial Results

iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $ACCS$NXGL

iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $ACCS$NXGL

$ACCS$NXGL SEC Filings

NexGel Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

NexGel Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure

SEC Form 424B5 filed by NexGel Inc

$ACCS$NXGL Press Releases

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence

NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor

$ACCS$NXGL Insider Purchases

Director Pollard Wesley T bought $18,420 worth of shares (2,000 units at $9.21) (SEC Form 4)

Chief Executive Officer Levy Adam R. bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 1% to 333,196 units (SEC Form 4)

Director Zeldis Jerome B bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 4% to 106,664 units (SEC Form 4)

$ACCS$NXGL Analyst Ratings

Maxim Group initiated coverage on NexGel with a new price target

$ACCS$NXGL Insider Trading

Chief Executive Officer Levy Adam R. sold $15,947 worth of shares (10,000 units at $1.59), decreasing direct ownership by 3% to 357,692 units (SEC Form 4)

Chief Executive Officer Levy Adam R. sold $10,084 worth of shares (4,000 units at $2.52), decreasing direct ownership by 1% to 367,692 units (SEC Form 4)

Director Henry Scott Robert sold $20,360 worth of shares (8,000 units at $2.55), decreasing direct ownership by 7% to 113,356 units (SEC Form 4)

$ACCS$NXGL Leadership Updates

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor

NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardiello, CPA, to its Board of Directors

$ACCS$NXGL Financials

NEXGEL Reports Third Quarter 2025 Financial Results

NEXGEL to Report Third Quarter 2025 Financial Results on November 11th

NEXGEL Reports Second Quarter 2025 Financial Results

Recent Analyst Ratings for
$ACCS
$NXGL

Recent Analyst Ratings for
$ACCS
$NXGL

$ACCS
$NXGL
SEC Filings

$ACCS
$NXGL
Press Releases

$ACCS
$NXGL
Insider Purchases

$ACCS
$NXGL
Analyst Ratings

$ACCS
$NXGL
Insider Trading

$ACCS
$NXGL
Leadership Updates

$ACCS
$NXGL
Financials